Data is being updated
Roll-call votes · EU Parliament
How Ryszard voted.
Plenary sitting today: 7 October 2026
Ryszard Czarnecki
Poland POL
Speeches 89
Mandate 2024–2029
Voting Pattern –
Loading…
– – – –
Unable to load stats
Legislative record 184 documents
Joint motions
114 62.0%
Reports
67 36.4%
Motions
3 1.6%

Ryszard Czarnecki (NI, Poland) — 1818 Roll-call votes · EU Parliament: 1038 For (57.1%), 322 Against (17.7%), 239 Abstention (13.1%), 219 Did not vote (12.0%).

Roll-call votes · EU Parliament

How Ryszard Czarnecki voted.

Plenary sitting today: 7 October 2026
Motion adopted

Laying a framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest, and amending Regulation (EU) 2024/795 (Motion adopted): 503 For, 57 Against, 108 Abstention, 67 Did not vote (735 Members). Ryszard Czarnecki: Did not vote.

20 Jan
2026
20. Jan 2026 · A10-0272/2025
Laying a framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest, and amending Regulation (EU) 2024/795
A10-0272/2025
My vote Did not vote
For
503
Motion rejected

Laying a framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest, and amending Regulation (EU) 2024/795 (Motion rejected): 44 For, 600 Against, 13 Abstention, 78 Did not vote (735 Members). Ryszard Czarnecki: Did not vote.

20 Jan
2026
20. Jan 2026 · A10-0272/2025
Laying a framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest, and amending Regulation (EU) 2024/795
A10-0272/2025
My vote Did not vote
Against
600
Motion adopted

Laying down Union procedures for the authorisation and supervision of medicinal products for human use and establishing rules governing the European Medicines Agency, amending Regulation (EC) No 1394/2007 and Regulation (EU) No 536/2014 and repealing Regulation (EC) No 726/2004, Regulation (EC) No 141/2000 and Regulation (EC) No 1901/2006 (Motion adopted): 488 For, 67 Against, 34 Abstention, 224 Did not vote (813 Members). Ryszard Czarnecki: Did not vote.

10 Apr
2024
10. Apr 2024 · A9-0141/2024
Laying down Union procedures for the authorisation and supervision of medicinal products for human use and establishing rules governing the European Medicines Agency, amending Regulation (EC) No 1394/2007 and Regulation (EU) No 536/2014 and repealing Regulation (EC) No 726/2004, Regulation (EC) No 141/2000 and Regulation (EC) No 1901/2006
A9-0141/2024
My vote Did not vote
For
488
Showing 3 of 3
Follow us on Instagram @checksomevotes @checksomevotes_en